sameAs
Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease.Glycogen phosphorylation and Lafora disease.Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative DiseasesLafora Disease during a Seven-Year Period, Bosnian and Herzegovinian experience
P921
description
Krankheit
@de
Lafora disease (LD) is a rare, ...... ogressive neurological decline
@en
مرض يصيب الإنسان
@ar
name
Enfermedad de Lafora
@es
Lafora disease
@en
Lafora-Krankheit
@de
Laforan tauti
@fi
Padaczka miokloniczna Lafory
@pl
syndrome de Lafora
@fr
ラフォラ病
@ja
type
label
Enfermedad de Lafora
@es
Lafora disease
@en
Lafora-Krankheit
@de
Laforan tauti
@fi
Padaczka miokloniczna Lafory
@pl
syndrome de Lafora
@fr
ラフォラ病
@ja
altLabel
EPM2
@en
Epilepsy progressive myoclonic 2
@en
Epilepsy, Progressive Myoclonic, 2A
@en
Epilepsy, Progressive Myoclonic, 2B
@en
Lafora Body Disease
@en
Lafora Disease
@en
Lafora Progressive Myoclonic Epilepsy
@en
Lafora body disorder
@en
Lafora disease (disorder)
@en
Lafora's disease
@en
prefLabel
Enfermedad de Lafora
@es
Lafora disease
@en
Lafora-Krankheit
@de
Laforan tauti
@fi
Padaczka miokloniczna Lafory
@pl
syndrome de Lafora
@fr
ラフォラ病
@ja
P279
P2888
P2892
P672
P2581
P486
P6366
P646
P1748
P1995
P2581
P279
P2892
P3827
lafora-disease